@article{cd7d6a08639f48f3844ad7d2577b6a48,
title = "Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer: Clinical and Experimental Metastasis",
keywords = "Inflammation, Neutrophil, Nivolumab, Non-small cell lung cancer, Osteopontin, C reactive protein, gamma glutamyltransferase, nivolumab, osteopontin, adult, Article, cancer survival, disease severity, enzyme linked immunosorbent assay, female, follow up, gamma glutamyl transferase blood level, human, hypoalbuminemia, immune response, liver metastasis, lymphocyte count, major clinical study, male, metastasis, mortality rate, neutrophil count, non small cell lung cancer, overall survival, protein blood level, treatment response",
author = "F. Carbone and F. Grossi and A. Bonaventura and A. Vecchi{\'e} and S. Minetti and N. Bardi and E. Elia and A.M. Ansaldo and D. Ferrara and E. Rijavec and {Dal Bello}, M.G. and F. Biello and G. Rossi and M. Tagliamento and A. Alama and S. Coco and P. Spallarossa and F. Dallegri and C. Genova and F. Montecucco",
note = "Export Date: 30 January 2020 CODEN: CEXMD Correspondence Address: Carbone, F.; First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, Italy; email: federico.carbone@unige.it",
year = "2019",
doi = "10.1007/s10585-019-09984-z",
language = "English",
volume = "36",
pages = "449--456",
journal = "Clin. Exp. Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "5",
}